miRCURY LNA miRNA Inhibitor Control (1)

QIAGEN offers a negative control LNA inhibitor designed for assay validation and baseline controls in miRNA functional studies. The control is used to establish baseline effects of transfection and off-target responses when assessing specific miRNA inhibition experiments.

The inhibitor control sequence is designed not to target known miRNAs, and shares the same chemistry and formulation as active inhibitors for consistent control conditions. Two pre-designed negative control options are available: Control A (for any organism) and Control B (for human, mouse, rat), both with sequences sharing less than 70% homology. The product is part of QIAGEN's miRCURY LNA miRNA Inhibitor product line, which uses LNA technology with sequences complementary to target miRNAs.

For storage, the control should be kept at -20°C and handled identically to test inhibitors. Companion Power Inhibitors within the same product family feature a phosphorothioate (PS) backbone for enhanced stability in cases where transfection is difficult or miRNA expression levels are high.